Senda Biosciences, Inc. is a pioneering biotech company focused on transforming human health through advanced mRNA therapeutics and vaccines. Leveraging nature's evolved systems, Senda develops SendRNA™ medicines that target genetic, autoimmune, metabolic diseases, and oncology indications with unprecedented precision and potency. Based in Cambridge, MA, the company’s proprietary platform offers a unique approach to programmable medicines by harnessing natural nanoparticles for cellular delivery.
Sail Biomedicines is seeking a Director/Senior Director of DMPK & Clinical Pharmacology to lead drug candidate transitions into clinical development. This role requires a strategic, visionary thinker with hands-on experience, strong communication skills, and expertise in DMPK and Clinical Pharmacology. The focus is on driving preclinical and clinical development, ensuring scientific rigor and alignment with program needs.
Senda Biosciences, Inc. is a pioneering biotech company focused on transforming human health through advanced mRNA therapeutics and vaccines. Leveraging nature's evolved systems, Senda develops SendRNA™ medicines that target genetic, autoimmune, metabolic diseases, and oncology indications with unprecedented precision and potency. Based in Cambridge, MA, the company’s proprietary platform offers a unique approach to programmable medicines by harnessing natural nanoparticles for cellular delivery.